Kappa opioid receptors on three related thymoma cell lines. Differences in receptor-effector coupling.
Bidlack
J M
JM
Department of Pharmacology, University of Rochester School of Medicine and Dentistry, New York 14642, USA.
Joseph
D B
DB
Lawrence
D M
DM
D000262:Adenylyl Cyclases / Q000378:metabolism; D000700:Analgesics / Q000378:metabolism; D000818:Animals; D044482:Benzeneacetamides; D002462:Cell Membrane / Q000201:enzymology / Q000378:metabolism; D020558:GTP Phosphohydrolases / Q000378:metabolism; D007700:Kinetics; D051379:Mice; D011759:Pyrrolidines / Q000378:metabolism; D017473:Receptors, Opioid, kappa / Q000378:metabolism*; D013945:Thymoma / Q000201:enzymology / Q000378:metabolism*; D013953:Thymus Neoplasms / Q000201:enzymology / Q000378:metabolism*; D014407:Tumor Cells, Cultured
D000700:Analgesics; D044482:Benzeneacetamides; D011759:Pyrrolidines; D017473:Receptors, Opioid, kappa; D020558:GTP Phosphohydrolases; D000262:Adenylyl Cyclases; C045444:U 69593